Practice
Featured experience
Nordson $800 million acquisition of Atrion
We are advising Nordson on the acquisition
Gilead Sciences $4.3 billion acquisition of CymaBay Therapeutics
We are advising Gilead Sciences on the acquisition
Owens Corning $3.9 billion acquisition of Masonite International
We are advising Owens Corning on the acquisition
Equinix $2 billion at-the-market offering
We advised Equinix on the offering
Morgan Stanley Bank $2 billion senior notes offering
We advised Morgan Stanley Bank on its 3(a)(2) notes offering
DXC Technology $230 million revolving facility increase
We advised the borrower on the financing
GSK exclusive license agreement for HS-20089 with Hansoh Pharma
We advised GSK on the transaction
GSK collaboration extension and new data licensing agreement with 23andMe
We advised GSK on the transaction
UCT acquisition of HIS Innovations Group
We advised UCT on the acquisition
Semtech $250 million convertible senior notes offering
We advised Semtech on its private placement of 4% convertible senior notes due 2028
MSCI acquisition of Trove Research
We are advising MSCI on the acquisition
ExxonMobil $59.5 billion acquisition of Pioneer Natural Resources
We are advising ExxonMobil on the transaction
JPMorgan Chase medium-term note program
We advised JPMorgan Chase on the euro note program
NICE acquisition of LiveVox
We are advising NICE on the acquisition